Analysis of response to infliximab in ankylosing spondylitis (AS) according to the axial and/or peripheral involvement. autoantibodies and drop outs are more frequent in the peripheral subset
2006-01-01 Lizzio, Mm; Peluso, G; Gremese, E; Zoli, A; Ferraccioli, G
Neuropsychiatric involvement and SLE: performance of a new algorithm for attribution of np events tested on an italian multicenter cohort
2012-01-01 Bortoluzzi, A; Bombardieri, S; Casu, C; Conti, F; De Vita, S; Doria, A; Farina, I; Ferraccioli, G; Gremese, E; Mansutti, E; Mosca, M; Padovan, M; Piga, M; Tincani, A; Tomietto, P; Tani, C; Valesini, G; Zen, M; Mathieu, A; Govoni, M; on behalf of the Italian Study Group for the Neuropsychiatric Involvement in Systemic Lupus, Erythematosus
Metaflammation, PEDF and Chemerin: Potential Systemic Factors Which Link Obesity To Response To Therapy In Early Rheumatoid Arthritis.
2013-01-01 Gremese, E; Tolusso, B; Fedele, Al; Gigante, Mr; Carbonella, A; Canestri, S; Di Mario, C; Ferraccioli, G
Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden
2006-01-01 Gremese, E; De Simone, M; Sallì, S; Tolusso, B; Pietrapertosa, D; Bosello, Sl; Peluso, G; Ferraccioli, G
Peripheral blood B cells subsets in patients with systemic lupus erythematosus: correlation with disease activity and organ involvement
2010-01-01 Gremese, E; Tolusso, B; Michelutti, A; Canestri, S; Nowik, M; Petricca, L; Laria, A; D'Antona, G; Ferraccioli, G
B-cell depletion in rheumatoid arthritis: searching for serologic and clinical baseline factors that could predict long-term efficacy
2010-01-01 Peluso, G; Faustini, F; Gremese, E; D'Antona, G; Laria, A; Tolusso, B; Ferraccioli, G
The Role of Microrna-34 and Microrna-22 in Dendritic Cells and Monocyte Activation in Rheumatoid Arthritis
2011-01-01 Alivernini, S; Gilchrist, Ds; Crawford, L; Ballantine, L; Hunter, J; Baxter, D; Tolusso, B; Gremese, E; FerraccioliG Iain, B. McInnes2 and Mariola Kurowska-Stolarska2.
Off-label use of rituximab for SLE in Europe: a comparison to patients treated with conventional immunosuppressive medications
2013-01-01 van Vollenhoven, Rf; Mild, M; Dörner, T; Gremese, E; Houssiau, F; Huizinga, T; Isenberg, Da; Kovács, L; Ruiz-Irastorza, G; Squatrito, E; Emmi, L; Voskuyl, A; Mosca, M; Castro, A; Iuliano, A; Inanc, M; Szücs, G; Doria, A; Jacobsen, S; for the IRBIS-EMA study, Group
Antineutrophil cytoplasmic autoantibodies (ANCA) positivity as a red flag of severe disease in lupus nephritis
2013-01-01 Messuti, L; Gremese, E; Petricca, L; Gigante, Mr; Marino, G; Nowik, M; Ferraccioli, G
Minimal disease activity in early and longstanding rheumatoid arthritis
2007-01-01 Pietrapertosa, D; Salaffi, F; Morelli, A; Fedele, A; Gremese, E; Tolusso, B; Ferraccioli, G
B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile
2009-01-01 Faustini, F; D'Antona, G; Laria, A; Peluso, G; Tolusso, B; Bosello, Sl; De Santis, M; Gremese, E; Ferraccioli, G
Circulating Human Collagen II-Reactive T Cell in Early Rheumatoid Arthritis Produce IL17.
2011-01-01 Fedele, Al; Nicolo`c, ; Di Sante, G; Tolusso, B; Bosello, Sl; Gremese, E; Ria, F; Ferraccioli, G
Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement
2007-01-01 Gremese, E; Tolusso, B; Costanzi, S; Michelutti, A; Ferraccioli, G
A brief battery for the evaluation of cognitive deficits in italian SLE patients
2005-01-01 Tomietto, P; Annese, A; Venturini, P; Tolusso, B; Gremese, E; Ferraccioli, G
Perception of health status in young adult patients with Juvenile idiopatic arthritis
2011-01-01 Messuti, L; D’Antona, G; Gremese, E; Petricca, L; Ferraccioli, G
Minimal disease activity in early and longstanding rheumatoid arthritis
2007-01-01 Pietrapertosa, D; Salaffi, F; Morelli, A; Fedele, A; Gremese, E; Tolusso, B; Ferraccioli, G
Association of the 22 genotype of enhancer HS1,2A of the Ig heavy 3′ regulatory region with non response to DMARDS and response to rituximab in rheumatoid arthritis patients
2013-01-01 Tolusso, B; Gremese, E; Fedele, Al; Serone, E; Frezza, D; Gigante, Mr; Nowik, M; Canestri, S; Carbonella, A; Ferraccioli, G
Synovial membrane hypertrophy and power doppler positivity predict clinical relapse in long-standing RA patients reaching DAS disease remission under biologic treatment: prospective 5 years follow-up real-life analysis
2013-01-01 Alivernini, S; Peluso, G; Gigante, Mr; Fedele, Al; Giammarioli, E; Berardi, G; Correra, M; Canestrari, Gb; De Luca, G; Rucco, M; Simone, D; Tolusso, B; Bosello, Sl; Gremese, E; Ferraccioli, G
Tocilizumab in the treatment of arthritis: response to therapy and evaluation of B cells subsets after 4 months treatment
2011-01-01 Di Blasi Lo Cuccio, C; Gremese, E; Faustini, F; Peluso, G; Tolusso, B; Canestri, S; Bosello, S; Ferraccioli, Gf
Long-term anti-TNF therapy and risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison among adalimumab, etanercept and infliximab
2011-01-01 Atzeni, F; Biasi, D; Botsios, C; Cipriani, P; Ferraccioli, G; Ferri, C; Galeazzi, M; Gerli, R; Giacomelli, R; Giardina, A; Gorla, R; Govoni, M; Grassi, W; Gremese, E; Iannone, F; Marchesoni, A; Punzi, L; Salaffi, F; Sebastiani, M; Triolo, G; Ziglioli, T; Lapadula, G; Sarzi-Puttini, P; Gisea,
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Analysis of response to infliximab in ankylosing spondylitis (AS) according to the axial and/or peripheral involvement. autoantibodies and drop outs are more frequent in the peripheral subset | 1-gen-2006 | Lizzio, Mm; Peluso, G; Gremese, E; Zoli, A; Ferraccioli, G | |
| Neuropsychiatric involvement and SLE: performance of a new algorithm for attribution of np events tested on an italian multicenter cohort | 1-gen-2012 | Bortoluzzi, A; Bombardieri, S; Casu, C; Conti, F; De Vita, S; Doria, A; Farina, I; Ferraccioli, G; Gremese, E; Mansutti, E; Mosca, M; Padovan, M; Piga, M; Tincani, A; Tomietto, P; Tani, C; Valesini, G; Zen, M; Mathieu, A; Govoni, M; on behalf of the Italian Study Group for the Neuropsychiatric Involvement in Systemic Lupus, Erythematosus | |
| Metaflammation, PEDF and Chemerin: Potential Systemic Factors Which Link Obesity To Response To Therapy In Early Rheumatoid Arthritis. | 1-gen-2013 | Gremese, E; Tolusso, B; Fedele, Al; Gigante, Mr; Carbonella, A; Canestri, S; Di Mario, C; Ferraccioli, G | |
| Metabolic syndrome in autoimmune diseases: prevalence and relationship with the inflammatory burden | 1-gen-2006 | Gremese, E; De Simone, M; Sallì, S; Tolusso, B; Pietrapertosa, D; Bosello, Sl; Peluso, G; Ferraccioli, G | |
| Peripheral blood B cells subsets in patients with systemic lupus erythematosus: correlation with disease activity and organ involvement | 1-gen-2010 | Gremese, E; Tolusso, B; Michelutti, A; Canestri, S; Nowik, M; Petricca, L; Laria, A; D'Antona, G; Ferraccioli, G | |
| B-cell depletion in rheumatoid arthritis: searching for serologic and clinical baseline factors that could predict long-term efficacy | 1-gen-2010 | Peluso, G; Faustini, F; Gremese, E; D'Antona, G; Laria, A; Tolusso, B; Ferraccioli, G | |
| The Role of Microrna-34 and Microrna-22 in Dendritic Cells and Monocyte Activation in Rheumatoid Arthritis | 1-gen-2011 | Alivernini, S; Gilchrist, Ds; Crawford, L; Ballantine, L; Hunter, J; Baxter, D; Tolusso, B; Gremese, E; FerraccioliG Iain, B. McInnes2 and Mariola Kurowska-Stolarska2. | |
| Off-label use of rituximab for SLE in Europe: a comparison to patients treated with conventional immunosuppressive medications | 1-gen-2013 | van Vollenhoven, Rf; Mild, M; Dörner, T; Gremese, E; Houssiau, F; Huizinga, T; Isenberg, Da; Kovács, L; Ruiz-Irastorza, G; Squatrito, E; Emmi, L; Voskuyl, A; Mosca, M; Castro, A; Iuliano, A; Inanc, M; Szücs, G; Doria, A; Jacobsen, S; for the IRBIS-EMA study, Group | |
| Antineutrophil cytoplasmic autoantibodies (ANCA) positivity as a red flag of severe disease in lupus nephritis | 1-gen-2013 | Messuti, L; Gremese, E; Petricca, L; Gigante, Mr; Marino, G; Nowik, M; Ferraccioli, G | |
| Minimal disease activity in early and longstanding rheumatoid arthritis | 1-gen-2007 | Pietrapertosa, D; Salaffi, F; Morelli, A; Fedele, A; Gremese, E; Tolusso, B; Ferraccioli, G | |
| B-cell directed therapy in rheumatoid arthritis: predictive factors of efficacy and assessment of regeneration profile | 1-gen-2009 | Faustini, F; D'Antona, G; Laria, A; Peluso, G; Tolusso, B; Bosello, Sl; De Santis, M; Gremese, E; Ferraccioli, G | |
| Circulating Human Collagen II-Reactive T Cell in Early Rheumatoid Arthritis Produce IL17. | 1-gen-2011 | Fedele, Al; Nicolo`c, ; Di Sante, G; Tolusso, B; Bosello, Sl; Gremese, E; Ria, F; Ferraccioli, G | |
| Anti-nucleosome antibodies: correlations with activity and chronicity disease indexes in systemic lupus erythematosus patients with renal involvement | 1-gen-2007 | Gremese, E; Tolusso, B; Costanzi, S; Michelutti, A; Ferraccioli, G | |
| A brief battery for the evaluation of cognitive deficits in italian SLE patients | 1-gen-2005 | Tomietto, P; Annese, A; Venturini, P; Tolusso, B; Gremese, E; Ferraccioli, G | |
| Perception of health status in young adult patients with Juvenile idiopatic arthritis | 1-gen-2011 | Messuti, L; D’Antona, G; Gremese, E; Petricca, L; Ferraccioli, G | |
| Minimal disease activity in early and longstanding rheumatoid arthritis | 1-gen-2007 | Pietrapertosa, D; Salaffi, F; Morelli, A; Fedele, A; Gremese, E; Tolusso, B; Ferraccioli, G | |
| Association of the 22 genotype of enhancer HS1,2A of the Ig heavy 3′ regulatory region with non response to DMARDS and response to rituximab in rheumatoid arthritis patients | 1-gen-2013 | Tolusso, B; Gremese, E; Fedele, Al; Serone, E; Frezza, D; Gigante, Mr; Nowik, M; Canestri, S; Carbonella, A; Ferraccioli, G | |
| Synovial membrane hypertrophy and power doppler positivity predict clinical relapse in long-standing RA patients reaching DAS disease remission under biologic treatment: prospective 5 years follow-up real-life analysis | 1-gen-2013 | Alivernini, S; Peluso, G; Gigante, Mr; Fedele, Al; Giammarioli, E; Berardi, G; Correra, M; Canestrari, Gb; De Luca, G; Rucco, M; Simone, D; Tolusso, B; Bosello, Sl; Gremese, E; Ferraccioli, G | |
| Tocilizumab in the treatment of arthritis: response to therapy and evaluation of B cells subsets after 4 months treatment | 1-gen-2011 | Di Blasi Lo Cuccio, C; Gremese, E; Faustini, F; Peluso, G; Tolusso, B; Canestri, S; Bosello, S; Ferraccioli, Gf | |
| Long-term anti-TNF therapy and risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison among adalimumab, etanercept and infliximab | 1-gen-2011 | Atzeni, F; Biasi, D; Botsios, C; Cipriani, P; Ferraccioli, G; Ferri, C; Galeazzi, M; Gerli, R; Giacomelli, R; Giardina, A; Gorla, R; Govoni, M; Grassi, W; Gremese, E; Iannone, F; Marchesoni, A; Punzi, L; Salaffi, F; Sebastiani, M; Triolo, G; Ziglioli, T; Lapadula, G; Sarzi-Puttini, P; Gisea, |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista2184
Data di pubblicazione
- 2020 - 2026115
- 2010 - 20191351
- 2000 - 2009606
- 1990 - 1999111
- 1988 - 19891
Editore
- Nature Publishing Group4
- s.n4
- ICRS3
- Blackwell1
Rivista
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...124
- EUROPEAN UROLOGY. SUPPLEMENTS124
- GASTROENTEROLOGY123
- THE JOURNAL OF UROLOGY111
- DIGESTIVE AND LIVER DISEASE100
- THE JOURNAL OF NUCLEAR MEDICINE80
- ANNALS OF THE RHEUMATIC DISEASES69
- RADIOTHERAPY AND ONCOLOGY59
- ANNALS OF ONCOLOGY57
- JOURNAL OF CLINICAL ONCOLOGY45
Keyword
- Myelodysplastic syndrome8
- Survival4
- biomimetic3
- Mitochondrial ferritin3
- osteochondral3
- Prognosis3
- scaffold3
- Sideroblastic anemia3
- viscosupplementation3
- COLONOSCOPIC SURVEILLANCE2
Lingua
- eng817
- ita28
- und6
Accesso al fulltext
- no fulltext2131
- reserved51
- open2